StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
UBE-R.BK$0.54+0.00%
Fair $0.54+0.0%

UBE-R.BK

Ubon Bio Ethanol Public Company Limited

Consumer Defensive / Farm ProductsThailand

$0.54

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $0.54Fund rank 30/100 · Data gapFallback financials|
SA 49/C
F-Score: 3/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 26% · confianza 25%

FCF escenarios

weak_data · normalized FCF $840.3M · quality 54.0/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 37/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

49/100

C

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -1.8%, below the 5% threshold
Thesis & Journal · UBE-R.BKLocal privado en este navegador · Ubon Bio Ethanol Public Company Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$2.1B

P/E

N/A

•

EV/EBITDA

3.7x

↓

ROE

-1.8%

↓

Gross Margin

10.6%

↓

Debt/Equity

0.06

↓
52-Week Range$1
$0$1

TradingView lightweight chart

UBE-R.BK price, volumen y niveles de valoración

Último $0.807Periodo -65.0%
Fair value: $0.540

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-10.3%

FCF CAGR

+69.9%

FCF margin

21.2%

FCF / Net income

-10.66x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $5.19B · net income $-103.1M · FCF $1.10B

2022-FY → 2025-FY

Gross margin

10.6%-1.9% pts

Operating margin

-0.4%-5.4% pts

Net margin

-2.0%-6.6% pts

FCF margin

21.2%+18.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$5.19B$5.19B$6.47B$5.84B$7.20B
Net Income$-103.1M$-103.1M$252.5M$-96.6M$329.2M
EBITDA$424.6M$424.6M$682.2M$318.4M$732.8M
EPS-0.03-0.030.07-0.030.08
Gross Margin10.6%10.6%13.6%8.9%12.5%
Operating Margin-0.4%-0.4%4.4%-1.3%5.0%
Net Margin-2.0%-2.0%3.9%-1.7%4.6%
Balance Sheet
Debt/Equity0.060.060.140.210.14
Current Ratio2.922.92———
Cash Flow
Free Cash Flow$1.10B$1.10B$840.3M$44.7M$224.2M
Returns
ROE-1.8%-1.8%4.3%-1.7%5.5%
Valuation
P/E——10.42—16.79
EV/EBITDA3.733.734.4214.798.56
P/B0.370.370.450.680.92
Growth & Yield
Revenue Growth-19.7%-19.7%10.7%-18.9%—
EPS Growth-140.0%-140.0%360.0%-129.8%—
Dividend Yield1.9%1.9%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +48.6%

Total return

+48.6%

Start / end P/E

n/dx → n/dx

EPS bridge

0.07 → -0.03

Residual

+46.7%

EPS growthn/d
Multiple reratingn/d
Dividend+1.9%
Residual / FX / buybacks / cross-term+46.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.